Clinical Trials

Can SGLT2 Inhibitors Improve Kidney Oxygenation in Diabetic Patients?
Research & Development Can SGLT2 Inhibitors Improve Kidney Oxygenation in Diabetic Patients?

Patients with type 2 diabetes often confront a myriad of challenges, one of which is the detrimental impact on kidney function. Recent research has been focusing on how SGLT2 inhibitors, particularly canagliflozin, might offer a solution to these problems by improving kidney health and oxygenation.

Impact of Hormone Therapy and Puberty Blockers on Transgender Skeletons
Research & Development Impact of Hormone Therapy and Puberty Blockers on Transgender Skeletons

In the evolving landscape of transgender healthcare, a profound area of research delves into how hormone therapy and puberty blockers affect skeletal dimensions in transgender individuals. Presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool,

Zinc Deficiency Raises Lung Infection Risk Through IL-13 Pathway
Research & Development Zinc Deficiency Raises Lung Infection Risk Through IL-13 Pathway

In a groundbreaking study published in Nature Microbiology, researchers at Vanderbilt University Medical Center revealed a significant link between dietary zinc deficiency and the risk of lung infections, including those caused by Acinetobacter baumannii. This bacterium is a notorious agent in

Directed Evolution Enhances eVLPs for Efficient Gene Delivery Applications
Research & Development Directed Evolution Enhances eVLPs for Efficient Gene Delivery Applications

Engineered virus-like particles (eVLPs) are revolutionizing the field of gene delivery and editing. These particles are designed to safely and effectively deliver macromolecules, such as mRNAs, proteins, or ribonucleoproteins (RNPs), into cells. While Adeno-associated virus (AAV) vectors have been

Transformative Potential of GHRH in Treating Various Chronic Diseases
Research & Development Transformative Potential of GHRH in Treating Various Chronic Diseases

Growth hormone-releasing hormone (GHRH), also known as somatoliberin, has emerged as a significant focus in medical research due to its extensive biological activities and therapeutic potential. GHRH, a family of hypothalamic peptide hormones, plays a crucial role in stimulating and modulating the

Neoantigen DNA Vaccines Show Promise for Triple-Negative Breast Cancer
Research & Development Neoantigen DNA Vaccines Show Promise for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is known for its aggressive nature and limited treatment options. However, a recent breakthrough in personalized immunotherapy offers new hope for patients. Researchers have developed a neoantigen DNA vaccine platform that has shown promising results in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later